Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: J Psychosom Res. 2014 Mar 22;76(5):361–367. doi: 10.1016/j.jpsychores.2014.03.001

Table 1.

Demographics and PSG metrics for diagnostic and treatment PSGs

n 331
sex 54% male
age 54 (16, 89)
BMI 31 (27, 35)
ESS 8 (5, 11)
Time between studies (days) 93 (47, 161)
Dx PAP
Subj Lat (min) 30 (15, 60) 20 (15, 45)
Subj TST (min) 360 (300, 420) 360 (300, 420)
Subj # wakes 3 (2, 5) 3 (2, 5)
Subj WASO (min) 20 (10, 60) 20 (10, 45)
S-O Lat (min) 15 (3, 34.4) 10 (-3, 23.3)
S-O TST (min) −34 (−91, 14) −19 (−69, 36)*
S-O # wakes −17 (−26, −10) −16 (−23, −10)
S-O WASO (min) −16 (−46, 5) −22 (−49, −0)
TST (min) 383 (345,417) 374 (326,402)
Lat (min) 5 (2,10) 4 (1,10)
LPS (min) 12 (4,27) 13 (5,29)
REM Lat 124 (84,205) 104 (73,182)
N1% 14 (10,23) 12 (8,19)
N2% 55 (48,62) 52(45,62)
N3% 12 (5,19) 16 (8,24)
R% 14 (9,19) 16 (11,22)
Eff (%) 88 (80,94) 87 (78,93)
#30sW 22 (14,30) 20 (14,27)
#60sW 11 (6,16) 11 (7,16)
Sp AI (hr−1) 3 (2,5) 5 (3,7)
LMAI (hr−1) 1 (0,4) 2 (0,6)
PLMI (hr−1) 4 (1,17) 7 (1,24)
AHI (hr−1) 13 (8,20) 2 (1,4)*
AHI Supine 17 (10,30) 2 (1,5)*
AHI REM 26 (12,44) 2 (0,5)*
RDI (hr−1) 27 (17,37) 4 (2,7)*
O2 nadir REM 85 (80,89) 92 (89,94)
O2 nadir NR 85 (82,88) 90 (88,92)

Median values, with 25-75% range shown in parentheses, separated by commas.

*

Significant differences using Kruskal-Wallis with Dunn's correction are given by.

AHI, apnea-hypopnea index; BMI, body mass index; Dx, diagnostic PSG; Eff, efficiency; ESS; Epworth Sleepiness Scale; Lat, latency; LMAI, limb movement arousal index; LPS, latency to persistent sleep; min, minutes; N1-N3, NREM stages of sleep; O2, oxygen; REM, rapid eye movement; PAP, positive airway pressure treatment PSG; PLMI, periodic limb movement index; S-O, subjective-objective difference; Sp AI, spontaneous arousals; subj, subjective; TST, total sleep time; WASO, wake after sleep onset; #30sW, number of wakes ≥30 seconds long; #60sW, number of wakes ≥60 seconds long.

HHS Vulnerability Disclosure